Abstract

Prognostication in inflammatory bowel disease

Front Med (Lausanne). 2022 Oct 6;9:1025375. doi: 10.3389/fmed.2022.1025375.eCollection 2022.

 

Elizabeth A Spencer 1Manasi Agrawal 2 3Tine Jess 3 4

 
     

Author information

1Division of Pediatric Gastroenterology and Nutrition, Icahn School of Medicine, Mount Sinai Hospital, New York, NY, United States.

2Division of Gastroenterology, Icahn School of Medicine, Mount Sinai Hospital, New York, NY, United States.

3Center for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Aalborg University, Aalborg, Denmark.

4Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.

Abstract

Personalized care in inflammatory bowel diseases (IBD) hinges on parsing the heterogeneity of IBD patients through prognostication of their disease course and therapeutic response to allow for tailor-made treatment and monitoring strategies to optimize care. Herein we review the currently available predictors of outcomes in IBD and those on the both near and far horizons. We additionally discuss the importance of worldwide collaborative efforts and tools to support clinical use of these prognostication tools.

 

 

© Copyright 2013-2022 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.